Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain.

Background: It has been repetitively shown that the transcription factors and are drastically downregulated in endometriotic lesions when compared with eutopic endometrium. These findings suggest that regulatory cascades involving DLX5/6 might be at the origin of endometriosis symptoms such as chronic pelvic pain (CPP). We have shown that inactivation of and in the mouse uterus results in an endometrial phenotype reminiscent of endometriosis.

Methods: We focused on genes that present a similar deregulation in endometriosis and in -null mice in search of new endometriosis targets.

Results: We confirmed a strong reduction of expression in endometriosis implants. We identified a signature of 30 genes similarly deregulated in human endometriosis implants and in -null mouse uteri, reinforcing the notion that the downregulation of is an early event in the progress of endometriosis. , a component of the α2δ family of voltage-dependent calcium channel complex, was strongly overexpressed both in mutant mouse uteri and in endometriosis implants, were also CACNA2D1 and CACNA2D2, other members of the α2δ family involved in nociception, are upregulated.

Conclusion: Comparative analysis of gene expression signatures from endometriosis and mouse models showed that calcium channel subunits α2δ involved in nociception can be targets for the treatment of endometriosis-associated pain. CACNA2D3 has been associated with pain sensitization and heat nociception in animal models. In patients, CACNA2D3 variants were associated with reduced sensitivity to acute noxious stimuli. As α2δs were targets of gabapentinoid analgesics, the results suggested the use of these drugs for the treatment of endometriosis-associated pain. Indeed, recent small-scale clinical studies have shown that gabapentin could be effective in women with CPP. The findings of this study reinforce the need for a large definitive trial.